The DOI matches its Crossref record.
Basic Clinical Radiobiology
Abstract
1.Introduction: the significance of radiobiology and radiotherapy for cancer treatment 2. Irradiation-induced damage and the DNA damage response 3. Cell death after irradiation: how, when and why cells die 4. Quantitating cell kill and cell survival 5. Models of radiation response 5. Dose-response relationships in radiotherapy 6. LET and RBE 7. Tumour growth and response to radiation 8. Fractionation: the L-Q approach 9. The L-Q approach in clinical practice 10. Modified fractionation 11. Time factors in normal-tissue response to radiation 12. The dose-rate effect 13. Pathogenesis of normal-tissue side-effects 14. The volume effect in radiotherapy 15. The oxygen effect and fractionated radiotherapy 16. The tumour microenvironment and cellular hypoxia responses 17. Therapeutic approaches to tumor hypoxia 18. Combined radiotherapy and chemotherapy 19. Retreatment tolerance of normal tissues 20.Molecular image-guided radiotherapy with positron emission tomography 21. Molecular-targeted agents for enhancing tumour response 22. Biological response modifiers in the clinic: tumor 22. Biological response modifiers: normal tissue 23. Molecular targeting and patient individualization 24.Protons and other ions in radiotherapy 25. Second cancers after radiotherapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Stewart, F. A., Akleyev, A. V., Hauer-Jensen, M., Hendry, J. H., Kleiman, N. J., MacVittie, T. J., Aleman, B. M., Edgar, A. B., Mabuchi, K., Muirhead, C. R., et al. (2012) · Annals of the ICRP · doi:10.1016/j.icrp.2012.02.001 · Cited by 1,604
Bentzen, S. M., Constine, L. S., Deasy, J. O., Eisbruch, A., Jackson, A., Marks, L. B., Ten Haken, R. K., & Yorke, E. D. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.09.040 · Cited by 1,257
Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements
Her, S., Jaffray, D. A., & Allen, C. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.012 · Cited by 865
Imaging hypoxia to improve radiotherapy outcome
Horsman, M. R., Mortensen, L. S., Petersen, J. B., Busk, M., & Overgaard, J. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.171 · Cited by 614
Gold nanoparticles for cancer radiotherapy: a review
Haume, K., Rosa, S., Grellet, S., Śmiałek, M. A., Butterworth, K. T., Solov’yov, A. V., Prise, K. M., Golding, J., & Mason, N. J. (2016) · Cancer Nanotechnology · doi:10.1186/s12645-016-0021-x · Cited by 445
The linear quadratic model: usage, interpretation and challenges
McMahon, S. J. (2018) · Physics in Medicine & Biology · doi:10.1088/1361-6560/aaf26a · Cited by 440
Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy
Meijer, T. W. H., Kaanders, J. H. A. M., Span, P. N., & Bussink, J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0858 · Cited by 433
Review of clinical brachytherapy uncertainties: Analysis guidelines of GEC-ESTRO and the AAPM
Kirisits, C., Rivard, M. J., Baltas, D., Ballester, F., De Brabandere, M., van der Laarse, R., Niatsetski, Y., Papagiannis, P., Hellebust, T. P., Perez-Calatayud, J., et al. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.11.002 · Cited by 314
Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
Cutter, D. J., Schaapveld, M., Darby, S. C., Hauptmann, M., van Nimwegen, F. A., Krol, A. D. G., Janus, C. P. M., van Leeuwen, F. E., & Aleman, B. M. P. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv008 · Cited by 310
Proton vs carbon ion beams in the definitive radiation treatment of cancer patients
Suit, H., DeLaney, T., Goldberg, S., Paganetti, H., Clasie, B., Gerweck, L., Niemierko, A., Hall, E., Flanz, J., Hallman, J., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.01.015 · Cited by 290
Tubiana, M. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.12.016 · Cited by 280
Zips, D., Zöphel, K., Abolmaali, N., Perrin, R., Abramyuk, A., Haase, R., Appold, S., Steinbach, J., Kotzerke, J., & Baumann, M. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.08.019 · Cited by 280
The FLUKA Code: An Accurate Simulation Tool for Particle Therapy
Battistoni, G., Bauer, J., Boehlen, T. T., Cerutti, F., Chin, M. P. W., Dos Santos Augusto, R., Ferrari, A., Ortega, P. G., Kozłowska, W., Magro, G., et al. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00116 · Cited by 272
Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome
Salem, A., Asselin, M.-C., Reymen, B., Jackson, A., Lambin, P., West, C. M. L., O’Connor, J. P. B., & Faivre-Finn, C. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx160 · Cited by 266
Bilynsky, C., Millot, N., & Papa, A. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10256 · Cited by 52
Neutron Exposures in Human Cells: Bystander Effect and Relative Biological Effectiveness
Seth, I., Schwartz, J. L., Stewart, R. D., Emery, R., Joiner, M. C., & Tucker, J. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098947 · Cited by 45
Self-citationCritical Considerations for the Design of Multi-Organ Microphysiological Systems (MPS)
Malik, M., Yang, Y., Fathi, P., Mahler, G. J., & Esch, M. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.721338 · Cited by 43
Radiotherapy in combination with vascular-targeted therapies
Ciric, E., & Sersa, G. (2010) · Radiology and Oncology · doi:10.2478/v10019-010-0025-9 · Cited by 30
Furusawa, Y., Nakano-Aoki, M., Matsumoto, Y., Hirayama, R., Kobayashi, A., & Konishi, T. (2017) · Journal of Radiation Research · doi:10.1093/jrr/rrx030 · Cited by 12
Metadata
- Authors
- Joiner, M. C., & van der Kogel, A.
- Venue
- CRC Press eBooks
- Publisher
- CRC Press
- Published
- 2009-03-27
- OpenAlex
- W1529490909
- Cited by
- 1,068
- References
- 0
- FWCI
- 83.99
- Type
- book
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.